IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — HCWB

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021
Cash & Equivalents0.741.231.102.441.111.001.164.0811.227.4518.3926.2215.4218.1215.135.05
Short-term Investments0.000.000.000.000.00----0.000.009.969.850.0016.9916.9724.99--
Accounts Receivable0.020.070.030.020.090.650.650.900.710.710.250.360.350.550.070.05
Total Current Assets1.141.721.592.901.892.092.396.2113.8519.8029.9428.7134.6337.9143.5610.05
Property, Plant & Equipment20.7520.7722.5022.6422.7622.8322.8122.5914.7812.6211.7410.960.911.011.271.39
Total Non-current Assets*25.6325.6223.8626.0124.3924.4624.4324.2221.7719.6813.5922.6512.7813.0512.852.99
Total Assets26.7727.3425.4528.9126.2926.5626.8230.4335.6239.4843.5351.3547.4150.9656.4113.03
Accounts Payable0.120.050.121.101.201.206.302.902.302.403.400.880.850.671.803.20
Short-term Debt6.566.586.816.426.236.34--------------------
Total Current Liabilities18.6519.9626.8626.8527.1430.0623.2213.415.424.544.522.291.141.422.394.17
Long-term Debt----0.000.377.716.469.908.276.336.366.396.45--------
Total Non-current Liabilities*0.691.620.692.127.716.469.908.276.336.366.396.500.100.140.0032.10
Total Liabilities*19.3421.5827.5528.9634.8536.5333.1221.6911.7510.9010.928.801.241.562.3936.27
Retained Earnings(110.26)(105.04)(109.24)(104.68)(102.75)(97.18)(93.28)(78.00)(59.85)(54.91)(50.61)(40.12)(36.21)(32.69)(27.46)(23.24)
Total Stockholder Equity7.435.76(2.11)(0.05)(8.56)(9.97)(6.30)8.7423.8728.5932.6242.5646.1749.4054.01(23.24)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue0.126.500.030.020.010.010.390.430.621.131.320.850.620.041.341.810.453.120.000.00
Cost of Revenue0.230.010.020.010.010.000.320.340.440.511.070.680.500.031.071.450.291.33----
Gross Profit(0.09)6.530.010.000.000.000.080.090.180.610.250.170.120.010.270.360.171.79----
Research & Development1.201.261.331.401.231.481.051.192.032.122.141.671.622.262.932.651.971.791.482.69
Selling, General & Admin1.871.831.491.882.102.23(2.38)1.641.595.993.633.593.013.123.011.731.711.881.631.40
Total Operating Expenses3.073.304.453.303.471.973.243.7815.328.1111.025.254.635.375.944.383.683.673.114.09
Operating Income(3.17)3.24(4.44)(3.29)(3.46)(1.97)(3.16)(3.69)(15.14)(7.49)(10.77)(5.08)(4.51)(5.36)(5.67)(4.02)(3.51)(1.88)(3.11)(4.09)
Interest Expense0.100.110.230.130.230.260.250.220.160.00-0.000.100.100.090.09----------
Pretax Income(5.22)3.80------------------------------------
Tax Provision0.000.330.000.00--0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Net Income(5.22)3.470.72(4.55)(1.93)(2.20)(3.37)(3.90)(15.28)(7.47)(10.68)(4.94)(4.30)(5.07)(5.42)(3.91)(3.51)(2.06)(3.17)(4.09)
Basic EPS(11.58)1.39(10.62)(12.12)(40.74)(0.30)(0.42)(0.60)(2.40)(1.20)(1.80)(0.84)(0.72)(0.14)(0.96)(0.66)(0.60)------
Diluted EPS(11.58)1.39(10.62)(12.12)(40.74)(0.30)(0.42)(0.60)(2.40)(1.20)(1.80)(0.84)(0.72)(0.84)(0.96)(0.66)(0.60)------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(3.97)(1.58)(3.36)(3.24)(3.28)(3.51)(2.83)(2.93)(4.86)(3.60)(3.89)(5.59)(9.39)(3.64)(3.79)(2.31)(2.69)(1.59)(3.38)(5.12)
Capital Expenditures----0.000.000.000.000.110.04(0.02)0.133.720.631.560.300.0710.170.010.020.020.00
Free Cash Flow*----(3.36)(3.24)(3.28)(3.51)(2.95)(2.96)(4.84)(3.73)(7.61)(6.22)(10.95)(3.94)(3.86)(12.48)(2.70)(1.62)(3.40)(5.12)
Investing Cash Flow----0.000.000.000.00(0.11)(0.04)0.02(0.13)(3.72)9.37(1.56)(0.30)(0.07)6.81(0.01)7.98(0.02)(34.97)
Financing Cash Flow3.480.854.211.904.61(0.05)6.622.801.924.22(0.02)(0.01)0.010.00(0.04)6.300.010.000.0150.16

* Derived from reported values